Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Explore a variety of travel cards that charge no annual fees. Save on costs while maximizing your travel rewards.
26,784 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A bold policy move could reshape mortgage markets and investor returns. Here’s what’s behind Trump’s strategy, the po...
Serve Robotics has faced a meaningful pullback, but a closer look at its partnerships, deployment plans, and unit eco...
When AI-assisted reviews uncover a serious flaw in a blockchain project, markets react fast. Anthropic's just found t...
Oracle shares have fallen sharply as investors reassess AI-related capital expenditure. This piece compares Oracle’s ...
Retirement income from Social Security isn’t a one-size-fits-all number. This deep dive explains what the average ret...
Choosing between a climate-focused global ETF and an emerging markets fund isn’t just about returns. This guide break...
Sellers turning to private listings may avoid public exposure, but new data suggests this approach can lead to lower ...
If president donald trump just signals a major crypto push, investors face a fast-moving regulatory landscape. This g...
Alphabet has quietly been reshaping the AI race. This article breaks down which segment is growing fastest, why it ma...
Apple launched the MacBook Neo at a budget price, signaling a potential breakthrough for Mac demand. This article bre...
Deregulation can tilt the odds for certain industries and investment themes. This guide explains how to spot opportun...